Well the ‘commercialisation ball’ is well & truly rolling for Trellus Health, who IPO’d in May raising £28.5m at 40p to commercialise its unique resilience/AI led telemedicine platform.
Indeed #TRLS unrivalled expertise on all things related to ‘chronic disease management’ (eg Crohn’s & Colitis) - alongside its proprietary science-enabled methodologies.
Means that its complete 'holistic' approach provides substantial patient quality of life, efficiency & cost saving benefits - whilst equally being applicable across other debilitating illnesses.
Today on top of its August ‘Demonstration’ contract with Mount Sinai Health System, TRLS announced its 1st ‘white-label’ agreement with Connected Health Medicine.
A New York based healthcare provider that will offer multidisciplinary patient care for chronic medical conditions to its clients. Here Trellus Health will supply its GRITTTM resilience system, the telehealth platform & associated scientific/technical expertise.
In my view this is a perfect ‘soft-launch’ deal that should thoroughly ‘road-test’ all the moving parts. Before later offering similar ‘highly scalable’ services to much larger healthcare providers, insurers, hospitals &/or medical organisations across not only the US (initially), but also later the world.
Exciting times ahead & very well done Marla Dubinsky, Laurie Keefer, PhD, Monique Fayad & the wider team.